Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at ZAR 3.58T, ahead of Johnson & Johnson (ZAR 3.43T) and Sanofi (ZAR 2.42T). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerZAR 3.58T
- Median
- ZAR 60.6B
- Combined market value
- ZAR 88.19T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 3.58T | ZAR 2.78T | ZAR 487.05 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 3.43T | ZAR 11.47T | ZAR 4,765.71 | 0.59% down | 38% up | ||
| 3 | SanofiSNY · Health Care | ZAR 2.42T | ZAR 1.96T | ZAR 817.74 | 0.02% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | ZAR 2.35T | ZAR 5.96T | ZAR 2,418.29 | 1.94% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | ZAR 2.3T | ZAR 8.83T | ZAR 4,995.34 | 0.84% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 1.96T | ZAR 4.81T | ZAR 3,103.58 | 0.98% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | ZAR 1.93T | ZAR 21.61T | ZAR 24,265.62 | 0.34% down | 35% up | ||
| 8 | NovartisNVS · Health Care | ZAR 1.91T | ZAR 5.11T | ZAR 2,705.03 | 1.18% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | ZAR 1.67T | ZAR 1.18T | ZAR 369.99 | 0.62% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.55T | ZAR 2.13T | ZAR 1,042.90 | 1.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | ZAR 1.49T | ZAR 3.12T | ZAR 1,801.98 | 0.00% | 17% down | ||
| 12 | GSKGSK · Health Care | ZAR 1.4T | ZAR 1.7T | ZAR 846.81 | 0.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | ZAR 1.39T | ZAR 3.04T | ZAR 690.10 | 1.43% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 700.9B | ZAR 858.7B | ZAR 735.94 | 0.41% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 697.7B | ZAR 1.71T | ZAR 16,537.56 | 0.38% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | ZAR 639.8B | ZAR 404.6B | ZAR 352.90 | 0.32% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 441.1B | ZAR 2.34T | ZAR 9,231.69 | 0.47% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | ZAR 376.2B | ZAR 101.3B | ZAR 148.79 | 0.23% up | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | ZAR 337.5B | ZAR 678.2B | ZAR 1,179.47 | 0.16% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | ZAR 266B | ZAR 589.2B | ZAR 1,450.04 | 0.98% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | ZAR 229.8B | ZAR 224.5B | ZAR 449.12 | 1.01% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | ZAR 221.4B | ZAR 548.3B | ZAR 889.29 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 200.6B | ZAR 265.9B | ZAR 4,142.39 | 0.05% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 140.9B | ZAR 799.2B | ZAR 6,997.02 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | ZAR 135.5B | ZAR 425.4B | ZAR 9,988.28 | 0.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 130.6B | ZAR 195.6B | ZAR 1,009.70 | 0.32% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 106B | ZAR 214.5B | ZAR 257.33 | 1.15% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | ZAR 98.2B | ZAR 481.1B | ZAR 663.96 | 0.28% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 85.4B | ZAR 356.1B | ZAR 2,658.59 | 1.24% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.3B | ZAR 126.9B | ZAR 364.32 | 0.28% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | ZAR 60.6B | ZAR 77.6B | ZAR 465.75 | 0.43% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | ZAR 49.9B | ZAR 86.3B | ZAR 1,032.58 | 0.55% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | ZAR 42.8B | ZAR 133.5B | ZAR 794.51 | 1.63% up | 58% up | ||
| 34 | InsmedINSM · Health Care | ZAR 39B | ZAR 457.4B | ZAR 2,085.11 | 0.53% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | ZAR 29.8B | ZAR 55.1B | ZAR 284.09 | 2.52% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | ZAR 26.8B | ZAR 101.1B | ZAR 5,052.11 | 0.03% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | ZAR 24.9B | ZAR 302.1B | ZAR 4,605.40 | 1.27% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | ZAR 24.5B | ZAR 124.3B | ZAR 892.56 | 0.46% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 23.8B | ZAR 104.2B | ZAR 737.32 | 0.29% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 21.7B | ZAR 166.1B | ZAR 7,149.98 | 1.50% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | ZAR 18.3B | ZAR 163.2B | ZAR 1,079.71 | 0.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | ZAR 16.1B | ZAR 146.5B | ZAR 5,242.43 | 0.09% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | ZAR 16.1B | ZAR 84.6B | ZAR 485.96 | 1.44% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | ZAR 16.1B | ZAR 256.5B | ZAR 1,316.48 | 0.35% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 14.5B | ZAR 103.3B | ZAR 1,582.23 | 0.04% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | ZAR 14.4B | ZAR 130.5B | ZAR 1,192.63 | 1.05% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | ZAR 13.4B | ZAR 111.1B | ZAR 2,734.96 | 0.81% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | ZAR 13.4B | ZAR 154.4B | ZAR 1,625.67 | 0.75% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 13.1B | ZAR 130.7B | ZAR 1,664.02 | 1.71% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | ZAR 12.9B | ZAR 147.6B | ZAR 184.57 | 0.56% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | ZAR 11.9B | ZAR 121.5B | ZAR 2,309.41 | 1.24% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | ZAR 11.5B | ZAR 139.3B | ZAR 2,134.82 | 0.45% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | ZAR 11.2B | ZAR 125.6B | ZAR 1,434.99 | 1.61% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | ZAR 10.4B | ZAR 83.1B | ZAR 865.73 | 1.51% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9.5B | ZAR 77.3B | ZAR 705.76 | 2.40% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | ZAR 9.1B | ZAR 83.9B | ZAR 1,490.04 | 0.41% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | ZAR 8.4B | ZAR 113.6B | ZAR 1,675.55 | 1.13% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 8.3B | ZAR 137B | ZAR 1,976.57 | 1.46% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | ZAR 7.6B | ZAR 68.9B | ZAR 503.30 | 0.41% down | 169% up | ||
| 60 | ErascaERAS · Health Care | ZAR 6.8B | ZAR 81B | ZAR 230.84 | 3.38% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 2.6B | ZAR 91.9B | ZAR 2,176.79 | 0.72% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2010 ZAR).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (ZAR 3.58T), Johnson & Johnson (ZAR 3.43T) and Sanofi (ZAR 2.42T) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of ZAR 88.19T as of 18 Nov 2026, 14:51 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.